Clean Energy Fuels (CLNE) closed the most recent trading day at $9, moving -1.75% from the previous trading session. This move lagged the S&P 500's daily gain of 0.35%.Prior to today's trading, shares of the provider of natural gas as an alternative fuel for vehicle fleets had lost 15.19% over the past month. This has lagged the Utilities sector's loss of 4.34% and the S&P 500's gain of 3.64% in that time.Investors will be hoping for strength from CLNE as it approaches its next earnings release, which is expected to be August 5, 2021. On that day, CLNE is projected to report earnings of $0 per share, which would represent year-over-year growth of 100%.CLNE's full-year Zacks Consensus Estimates are calling for earnings of -$0.18 per share and revenue of $346 million. These results would represent year-over-year changes of -350% and +18.61%, respectively.Investors should also note any recent changes to analyst estimates for CLNE. These revisions typically reflect the latest short-term business trends, which can change frequently. As such, positive estimate revisions reflect analyst optimism about the company's business and profitability.Based on our research, we believe these estimate revisions are directly related to near-team stock moves. To benefit from this, we have developed the Zacks Rank, a proprietary model which takes these estimate changes into account and provides an actionable rating system.Ranging from #1 (Strong Buy) to #5 (Strong Sell), the Zacks Rank system has a proven, outside-audited track record of outperformance, with #1 stocks returning an average of +25% annually since 1988. The Zacks Consensus EPS estimate remained stagnant within the past month. CLNE is holding a Zacks Rank of #3 (Hold) right now.The Utility - Gas Distribution industry is part of the Utilities sector. This group has a Zacks Industry Rank of 89, putting it in the top 36% of all 250+ industries.The Zacks Industry Rank includes is listed in order from best to worst in terms of the average Zacks Rank of the individual companies within each of these sectors. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.Make sure to utilize Zacks. Com to follow all of these stock-moving metrics, and more, in the coming trading sessions. Breakout Biotech Stocks with Triple-Digit Profit Potential The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases. Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +50%, +83% and +164% in as little as 2 months. The stocks in this report could perform even better.See these 7 breakthrough stocks now>>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Clean Energy Fuels Corp. (CLNE): Free Stock Analysis Report To read this article on Zacks.com click here.